HGH Fragment 176-191 is an injectable drug which is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. It is a part of the Growth Hormone molecule responsible for fat burning. The main effect of this compound is to reduce abdominal fat (mainly visceral fat), without compromising blood glucose levels and to increases muscle mass. Other positive features of HGH Fragment 176-191 include protein synthesis, vascularity from increased nitrogen retention, increased bone mineral density, better sleep, and increased strength through hyperplasia.
Many studies have showed the fact that the HGH Fragment 176-191 is an effective treatment for obesity and fat loss, and much safer than its Human Growth Hormone counterpart. The average dosage of the compound is 2-6 IU or (500-1000 mcg) per day split into two or three doses. Studies shows that the use of HGH Fragment 176-191 during 30 days produced a considerable reduction of body fat. In most studies no adverse side effects were reported with continuous use in the rational dosage limits.